gemcitabine

0:08:22

Pancreatic cancer properties describe gemcitabine response

0:01:30

Gemcitabine and Complementary Treatments for Cancer

0:01:00

Dr. Simeone on Benefit of Neoadjuvant Gemcitabine in Pancreatic Cancer

0:10:56

Debate: Optimal adjuvant chemotherapy for resected pancreatic cancer - Gemcitabine/capecitabine

0:02:30

#ESMO21 Highlights on gemcitabine vs mFOLFIRINOX in resected pancreatic cancer: PRODIGE 24/CCTG PA6

0:03:21

Low-dose gemcitabine for advanced CTCL

0:01:58

Gemcitabine-based chemotherapy after FOLFIRINOX in advanced pancreatic cancer

0:00:42

Gemcitabine

0:01:57

The protein RRP9 promotes gemcitabine resistance in pancreatic cancer by activating the AKT pathway

0:07:45

Phase-2 trial of gemcitabine, cisplatin + nivolumab with selective bladder sparing in MIBC patients

0:03:26

Dosing Options With Nab-Paclitaxel/Gemcitabine

0:04:05

Schedules for Gemcitabine, Nab-Paclitaxel for Pancreatic Cancer

0:02:06

CheckMate 901: nivolumab with gemcitabine-cisplatin in urothelial carcinoma

0:02:53

MP16-14: A Phase II Trial of Intravesical Gemcitabine and Docetaxel (GEMDOCE) Treatment of BCG-Naïve

0:03:39

KEYNOTE-966: pembrolizumab, gemcitabine and cisplatin for CCA

0:01:41

SELISARC: selinexor plus gemcitabine in leiomyosarcoma and osteosarcoma

0:09:50

GI Chemotherapy Education – GA/GemNab: Gemcitabine and Nab-paclitaxel (Abraxane®)

0:11:45

IA gemcitabine and IV gemcitabine/nab-paclitaxel show similar SAEs in LAPC

0:04:59

Gemcitabine plus cisplatin plus ipilimumab for metastatic urothelial cancer

0:12:37

Debate 10: What do we do after FOLFIRINOX? - Gemcitabine is Standard

0:01:27

A promising future for gemcitabine-oxaliplatin in cisplatin-unfit advanced urothelial carcinoma

0:01:24

PEGPH20 With Nab-paclitaxel/Gemcitabine in Pancreatic Cancer

0:04:21

10 Medicine of the week: Gemcitabine

0:02:07

Nivolumab plus gemcitabine-cisplatin shows benefit for locally advanced mUC